Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2008-07-14
2010-11-09
Steadman, David J (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S233000, C435S320100, C435S252300, C435S252330, C530S350000
Reexamination Certificate
active
07829311
ABSTRACT:
An acid-resistant peptide solubility tag (an “inclusion body tag”) is provided that is effective in producing peptides of interest in an insoluble form. Fusion peptide constructs comprising the inclusion body tag fused to a peptide of interest are provided. An acid cleavable peptide moiety separates the inclusion body tag from the peptide of interest so that acid hydrolysis can be used during subsequent processing steps to separate the tag from the desired peptide of interest. The present inclusion body tag's resistance to acid hydrolysis facilitates easier and cleaner separation of the peptide of interest after acid hydrolysis. Specifically, a ketosteroid isomerase-derived inclusion body tag is provided that has been engineered to be more resistant to acid hydrolysis.
REFERENCES:
patent: 5206154 (1993-04-01), Lai et al.
patent: 5215896 (1993-06-01), Keck et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5302526 (1994-04-01), Keck et al.
patent: 5330902 (1994-07-01), Keck et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5449754 (1995-09-01), Nishioka
patent: 5480971 (1996-01-01), Houghten et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5585275 (1996-12-01), Hudson et al.
patent: 5639603 (1997-06-01), Dower et al.
patent: 5643768 (1997-07-01), Kawasaki
patent: 5648244 (1997-07-01), Kuliopulos et al.
patent: 5658754 (1997-08-01), Kawasaki
patent: 5837500 (1998-11-01), Ladner et al.
patent: 6037145 (2000-03-01), Yabuta et al.
patent: 6207446 (2001-03-01), Szostak et al.
patent: 6214553 (2001-04-01), Szostak et al.
patent: 6242219 (2001-06-01), Better et al.
patent: 6258558 (2001-07-01), Szostak et al.
patent: 6261804 (2001-07-01), Szostak et al.
patent: 6281344 (2001-08-01), Szostak et al.
patent: 6312927 (2001-11-01), Hammond
patent: 6416950 (2002-07-01), Lohse et al.
patent: 6429300 (2002-08-01), Kurz et al.
patent: 6436665 (2002-08-01), Kuimelis
patent: 6518018 (2003-02-01), Szostak et al.
patent: 6602685 (2003-08-01), Lohse
patent: 6613548 (2003-09-01), Chu
patent: 6620419 (2003-09-01), Lintner
patent: 6696089 (2004-02-01), Kabanov et al.
patent: 6815426 (2004-11-01), Scialdone et al.
patent: 6846655 (2005-01-01), Wagner et al.
patent: 7074557 (2006-07-01), Osbourn et al.
patent: 7078197 (2006-07-01), Kurz et al.
patent: 7220405 (2007-05-01), Huang et al.
patent: 7276088 (2007-10-01), Huang et al.
patent: 7285264 (2007-10-01), O'Brien et al.
patent: 7309482 (2007-12-01), Buseman-Williams et al.
patent: 7427656 (2008-09-01), Decarolis et al.
patent: 7678883 (2010-03-01), Cheng et al.
patent: 2002/0098524 (2002-07-01), Murray et al.
patent: 2003/0152976 (2003-08-01), Janssen et al.
patent: 2003/0185870 (2003-10-01), Grinstaff et al.
patent: 2005/0221444 (2005-10-01), Williams et al.
patent: 2007/0065387 (2007-03-01), Beck et al.
patent: 2008/0107614 (2008-05-01), Fahnestock et al.
patent: 2008/0175798 (2008-07-01), Beck et al.
patent: WO9404688 (1994-03-01), None
patent: WO0179479 (2001-10-01), None
patent: WO2004000257 (2003-12-01), None
patent: WO2004048399 (2004-06-01), None
Rodriguez et al., Prot. Expression Purif. 28:224-231, 2003.
Kemp, D. J., Proc. Natl. Acad. Sci. USA 78(7): 4520-4524 (1981).
Chien et al., Proc. Natl. Acad. Sci. USA 88(21): 9578-82 (1991).
Deshpande, Mukund V., Appl. Biochem. Biotechnol., 36:227 (1992).
Dykes et al., Eur. J. Biochem., 174:411 (1988).
Schellenberger et al., Int. J. Peptide Protein Res., 41:326 (1993).
Shen et al., Proc. Nat. Acad. Sci. USA 81:4627 (1984).
Kempe et al., Gene, 39:239 (1985).
Ray et al., Bio/Technology, 11:64 (1993).
Lai et al., Antimicrob. Agents & Chemo., 37:1614 (1993).
Gram et al., Bio/Technology, 12:1017 (1994).
Kuliopulos et al., J. Am. Chem. Soc. 116:4599-4607 (1994).
Pilon et al., Biotechnol. Prog., 13:374-79 (1997).
Haught et al., Biotechnol. Bioengineer. 57:55-61 (1998).
Sulter et al., Arch. Microbiol., 153:485-489 (1990).
Tyas et al., EMBO Reports, 1(3):266-270 (2000).
Thornberry et al., J. Biol. Chem., 272:17907-17911 (1997).
Szoka et al., DNA, 5(1):11-20 (1986).
Bellion et al., Microb. Growth C1 Compd., [Int. Symp.], 7th (1993), 415-32.
Gavit, P. and Better, M., J. Biotechnol., 79:127-136 (2000).
The Following Applications Are Commonly Owned by Dupont and Are Reported Herein: U.S. Appl. No. 11/607,672, filed Dec. 1, 2006; U.S. Appl. No. 11/607,673, filed Dec. 1, 2006; U.S. Appl. No. 11/607,792, filed Dec. 1, 2006; U.S. Appl. No. 10/935,254, filed Sep. 7, 2004; U.S. Appl. No. 11/512,910, filed Aug. 30, 2006; U. S. Appl. No. 11/696,380, filed Apr. 4, 2007.
The Following Applications Are Commonly Owned by Dupont and Are Reported Herein: U.S. Appl. No. 11/877,692, filed Oct. 24, 2007; U.S. Appl. No. 11/607,723, filed Dec. 1, 2006; U.S. Appl. No. 11/607,734, filed Dec. 1, 2006; U.S. Appl. No. 60/951,754, filed Jul. 25, 2007.
DeCarolis Linda Jane
Fahnestock Stephen R.
E.I. du Pont de Nemours and Company
Steadman David J
LandOfFree
Ketosteroid isomerase inclusion body tag engineered to be... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ketosteroid isomerase inclusion body tag engineered to be..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketosteroid isomerase inclusion body tag engineered to be... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4204649